Your session is about to expire
← Back to Search
Behavioral Intervention
MBCT for Coronary Artery Disease
Phase 1
Waitlist Available
Led By Christina M Luberto, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age >18 years
Cardiologist-confirmed diagnosis of SCAD in the past 1-12 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This study is evaluating whether a mindfulness-based cognitive therapy intervention can improve sleep and anxiety in people with spontaneous coronary artery dissection.
Eligible Conditions
- Coronary Artery Disease
- Acute Coronary Syndrome
- Anxiety
- Sleep
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of actigraphy
Acceptability of study surveys
Feasibility of MBCT intervention: participant attendance rates
+8 moreSecondary outcome measures
Actigraphy physical activity outcomes
Actigraphy sleep outcomes
Attention regulation
+8 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Mindfulness-Based Cognitive TherapyExperimental Treatment1 Intervention
Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week group intervention (1.5-hour weekly sessions) that combines cognitive-behavioral therapy and mindfulness training to treat emotional problems.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBCT
2015
Completed Phase 1
~160
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,817 Total Patients Enrolled
21 Trials studying Coronary Artery Disease
10,490 Patients Enrolled for Coronary Artery Disease
Christina M Luberto, PhDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
27 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger